#healthcare #Abu Dhabi #United Arab Emirates #PureHealth #Profit

PureHealth Reports Impressive Financial Results

PureHealth Holding PJSC, the largest healthcare provider in the Middle East, shared its substantial financial results for the first nine months of 2026, reflecting robust growth and strategic expansion. The group reported a remarkable net profit of USD 482 million, which represents a 14.1% increase compared to the previous year. This strong performance underscores the effectiveness of PureHealth's diversified strategy aimed at enhancing its healthcare offerings both locally in the UAE and in international markets.

Revenue and EBITDA Growth

In terms of revenue, PureHealth experienced an 11.5% year-on-year increase, totaling USD 6.1 billion. This growth is attributed to the integration of Hellenic Healthcare Group (HHG) in Greece and Cyprus, which contributed USD 620 million to revenues. The revenue generated from the UK's Circle Health Group also played a pivotal role, achieving a 5.3% increase. Additionally, the group's insurance segment saw an impressive 11.7% revenue growth due to increased demand and effective pricing strategies.

Moreover, the group's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) rose by 20.4% year-on-year, reaching USD 1.1 billion, leading to a healthy EBITDA margin of 18.6%. This improvement is indicative of enhanced operational efficiencies and greater profitability from international operations, which now account for approximately 33% of the group's total revenue.

Strategic Initiatives and Operational Highlights

H.E. Kamal Al Maazmi, the Chairman of PureHealth, attributed the positive results to the group's strategy of building a more diversified healthcare model. The successful integration of HHG has significantly strengthened the group's footprint in Greece and Cyprus, while the ongoing development of Circle Health is enhancing its market presence in the UK. This approach not only broadens geographic reach but also diversifies the earnings base and solidifies PureHealth's standing in established healthcare markets.

Shaista Asif, the Group's CEO, commented on the measures taken to improve service offerings, including a recent agreement with Circle Health to take over certain laboratory operations in the UK. This move is intended to enhance the efficiency and effectiveness of diagnostic services. In the UAE, the company has been focusing on specialized care and capacity expansion, leading to increased patient activity, evidenced by a 9% rise in outpatient volumes and a 13% rise in inpatient volumes over the nine-month period.

As part of its digital transformation efforts, PureHealth is embedding AI and technological advancements across its operations, ranging from clinical management to patient engagement, aiming to elevate the standard of care delivered to patients.

Performance by Segments

International Care Revenue

The international segment has shown significant promise, with revenues soaring 53% year-on-year to USD 2.0 billion. The EBITDA from this segment also witnessed a remarkable growth of 63% year-on-year, driven largely by HHG's consolidation and positive results from the broader international portfolio.

UAE Healthcare Metrics

Conversely, the revenue from its UAE operations reported a decline of 9.2% year-on-year, amounting to USD 2.4 billion. This drop was primarily due to changes in revenue recognition and seasonal fluctuations in patient activity. Nevertheless, when normalized, the revenue indicated a 6% increase, demonstrating resilience post the initial quarter's challenges.

With an expanded operational capacity of 3,543 beds, utilization rates demonstrated a stronger performance with bed occupancy increasing to 76%.

Insurance Sector Performance

Within the insurance segment, revenue climbed by 11.7% year-on-year to USD 1.7 billion, propelled by policy renewals and disciplined pricing strategies. Daman, one of the group's insurance arms, continued to expand its multi-line offerings and recorded a net profit increase of 3.9%, as investments in market share yielded positive results.

Future Objectives and Outlook

PureHealth is optimistic about the future and aims to continue leveraging its international scale to drive operational performance. The company’s future growth is tied to the maturation of its international healthcare operations and a focus on maximizing patient engagement, service diversification, and technological integration. The strategic focus will remain on sustaining growth through careful capital allocation, organic investments, and potential acquisitions to enhance value.

In conclusion, PureHealth's strategic focus on growth, both in international markets and within its existing UAE framework, highlights its commitment to enhancing healthcare delivery while ensuring strong financial performance.